Galena Biopharma, Inc. GALE
No live quote for GALE yet.
Valuation
P/E 0.0×
FY 2024 5y median 0.0× FY 2025
P/S 0.0×
FY 2024 5y median 0.0× FY 2025
P/B 0.0×
FY 2024 5y median 0.0× FY 2025
P/FCF 0.0×
FY 2024 5y median 0.0× FY 2025
EV/EBITDA 2.5×
FY 2024 5y median 1.5× FY 2025
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2025
FCF Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2025
ROE -37.9%
FY 2024 5y median -182.1% FY 2025
ROIC -39.3%
FY 2024 5y median -170.2% FY 2025
ROA -34.3%
FY 2024 5y median -96.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income 10.3%
FY 2024 FY 2025
EPS (diluted) 50.0%
FY 2024 FY 2025
Free Cash Flow 19.8%
FY 2024 FY 2025
Financial Health
Current Ratio 10.7×
FY 2024 5y median 6.2× FY 2025
Quick Ratio 10.7×
FY 2024 5y median 6.2× FY 2025
Debt / Equity 0.0×
FY 2024 5y median 0.1× FY 2025
Net Debt / EBITDA 2.5×
FY 2024 5y median 1.5× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31